ISO/TR 12417-2:2022

Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information

Publication date:   Jul 7, 2022

General information

60.60 Standard published   Jul 7, 2022

ISO

ISO/TC 150/SC 2 Cardiovascular implants and extracorporeal systems

Technical Report

11.040.40   Implants for surgery, prosthetics and orthotics

Buying

  Published

PDF - €182.71

  English  



Buy

Scope

This document provides region-specific information for:
—    local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
—    changes related to the drug-containing part and how they are evaluated by different local regions.
For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.

Life cycle

PREVIOUSLY

WITHDRAWN
ISO/TR 12417-2:2017

NOW

PUBLISHED
ISO/TR 12417-2:2022
60.60 Standard published
Jul 7, 2022